Medrobotics Closes $26 Million Series E Financing

Company Prepares for European Commercialization of the Ground-Breaking Flex® System in Otolaryngology

RAYNHAM, Mass.--Medrobotics Corp., a surgical products company with core competencies in medical robotics, announced today that it had closed its $26 Million Series E Preferred Stock financing. Existing Medrobotics shareholders and undisclosed new investors participated in the Series E raise. Proceeds will be used for regulatory preparations and submissions and for anticipated commercial launches in Europe and the United States.


The Company recently announced that it had received the CE mark for its Flex® System. "The Flex® System is the first robot-assisted flexible endoscopic platform for use during surgical procedures," said Samuel Straface, Ph.D., President and CEO of Medrobotics. "It extends the capability of surgeons to look and reach around corners and operate in hard-to-reach and confined spaces."

The Flex® System enables minimally invasive surgical procedures where conventional line-of-sight technologies are either not feasible or sub-optimal. Surgeons can navigate the Flex® Scope around anatomical structures to hard-to-reach locations through a single access site, and then use the onboard high-definition vision system to precisely deploy a range of proprietary and third party flexible surgical instruments. The uniquely "wristed" 3mm Flex® Instruments, which have also received the CE mark, enable the surgeon to further extend his or her reach to important and often challenging areas of the anatomy.

Minimally invasive surgery has demonstrated advantages for patients and providers compared to traditional open procedures, decreasing hospital stays and recovery times. The Flex® System was designed to provide a cost-effective, easy-to-use, and efficient robot-assisted surgical platform for hospitals and surgeons seeking to provide minimally-invasive treatment options to more patients.

About Medrobotics

Medrobotics Corporation (www.Medrobotics.com) is a privately-held company headquartered in Raynham, Massachusetts that is developing and commercializing the Flex® System, a robotic-assist platform that provides surgeons with single-site access and visualization of hard-to-reach anatomical locations. The Company's vision is to provide more patients with access to minimally invasive surgery, and, having received the CE mark for its Flex® System, Medrobotics is preparing the commercial launch of its products in Europe. These products are not currently approved for sale in the U.S.

Featured Product

Universal Robots - Collaborative Robot Solutions

Universal Robots - Collaborative Robot Solutions

Universal Robots is a result of many years of intensive research in robotics. The product portfolio includes the UR5 and UR10 models that handle payloads of up to 11.3 lbs. and 22.6 lbs. respectively. The six-axis robot arms weigh as little as 40 lbs. with reach capabilities of up to 51 inches. Repeatability of +/- .004" allows quick precision handling of even microscopically small parts. After initial risk assessment, the collaborative Universal Robots can operate alongside human operators without cumbersome and expensive safety guarding. This makes it simple and easy to move the light-weight robot around the production, addressing the needs of agile manufacturing even within small- and medium sized companies regarding automation as costly and complex. If the robots come into contact with an employee, the built-in force control limits the forces at contact, adhering to the current safety requirements on force and torque limitations. Intuitively programmed by non-technical users, the robot arms go from box to operation in less than an hour, and typically pay for themselves within 195 days. Since the first UR robot entered the market in 2009, the company has seen substantial growth with the robotic arms now being sold in more than 50 countries worldwide.